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Abstract 
BACKGROUND: Hypertension (HTN) considers as one of the most common risk factors, which 
potentially raises the risk of cardiovascular disease. Regarding high prevalence of HTN among 
Iranian population this study designed to examine a range of socio-demographic and clinical 
variables to determine the association with failure to achieve blood pressure control in a cohort 
of hypertensive subjects. 
METHODS: This retrospective cohort study is a part of Isfahan cohort study which carried out on 
adults aged 35 years old or more. Subjects with confirmed HTN entered in this sub-study. For 
all subjects questionnaire included socio-demographic characteristics, clinical data and lifestyle 
behavior completed by trained nurses. Uncontrolled HTN was defined as systolic and diastolic 
blood pressure more than 140/90 in the presence or absent of pharmacological treatment. 
RESULTS: The prevalence of uncontrolled men was significantly higher than controlled in both 
2001 and 2007 (P < 0.001). A significant association was found between sex and control of 
blood pressure: compared with women, being men [odds ratio (OR) = 2.31; 95 % confidence 
interval (CI) = 1.64-3.24] was significantly associated with uncontrolled HTN in 2001 and  
(OR = 2.38; 95% CI = 1.78-3.18). Among lifestyle behaviors, tendency for more consumption of 
salty foods increased the risk of uncontrolled HTN in 2001 by 1.73 times [OR = 1.73, 95%  
CI = 1.20-2.50, (P = 0.003)]. Patients who were naive to mono-therapy without considering the 
type of antihypertensive drug were found to be associated with uncontrolled blood pressure  
(OR = 0.14; 95 % CI =0.1-0.2). 
CONCLUSION: Uncontrolled HTN was sex, marital status, diabetes, tendency to salty foods and 
medication adherence. Assessment of them presence of these risk factors is warranted to 
recommend an aggressive HTN management with the goal of reducing excessive risk of 
cardiovascular events caused by uncontrolled HTN. 
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Introduction 
Hypertension (HTN) considers as one of the most 
common risk factors, which potentially raises the 
risk of cardiovascular disease (CVD)1 and consider 
as a major public health problem in most developed 
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one billion individuals around the world, and the 
relationship between blood pressure and the risk of 
cardiovascular events is continuous, consistent, and 
independent of other risk factors.3 The national 
surveillance step-wise study which was done by the 
Iranian Ministry of Health demonstrated a 
prevalence of 25% for HTN among adults aged  
25-64 years.4 Moreover, according to available data, 
the rate of controlled HTN is widely varied among 
different countries ranged from 2.2% in Eastern 
Europe, < 5% in China to more than 38.0% in 
Western Europe, North America and 18.0% in 
Iran.5 It follows from all the above mentioned that a 
growing number of hypertensive patients are faced 
with undiagnosed HTN and or uncontrolled HTN.6 
More importantly, a large part of the patients 
(17.6% female and 18.0% of male) faced to 
uncontrolled HTN in Iran.7 
Several reports described key variables of 
uncontrolled HTN, which these barriers varied in 
different population. 6 poor medication, sedentary 
lifestyle and unhealthy eating, as well as high salt 
consumption, have defined as main fences in 
control of HTN around the world.8,9 
Many studies have examined risk factors for 
HTN, and several comprehensive management 
guidelines have been published.7,10-12 However, the 
risk factors for uncontrolled HTN are less well 
established.7,11,12 Previous studies claimed that 
individuals diagnosed with HTN whether they have 
untreated, undertreated or treatment-resistant HTN, 
have consistent characteristics that could provide 
insight to improve blood pressure control.12-14 
As intensive efforts need to control blood 
pressure and hence we have to evaluate determinants 
to achieving higher HTN control rates. The aim of 
this study was to examine a range of socio-
demographic and clinical variables to determine the 
association with failure to achieve blood pressure 
control in a cohort of hypertensive subjects. 
Materials and Methods 
The Isfahan cohort study (ICS), Iran, is a population-
based, ongoing longitudinal study of adults aged 35 
years old or more, living in urban and rural areas of 
three counties in central Iran namely Isfahan, 
Najafabad and Arak.15 Baseline data collection for the 
ICS began in 2001. Participants were selected by 
multistage random sampling and were recruited to 
reflect the age, sex and urban/rural distribution of the 
community.16,17 The Ethics Committee of the Isfahan 
Cardiovascular Research Center approved the study. 
The study sample included 6504 subjects 35 ≥ years of 
age (average 51.0 ± 11.7 years) that had complete 
demographic data, diagnoses, vital signs, pharmacy 
utilization, and personal information. In this sub-study, 
totally 1986 patients with a diagnosis of HTN were 
identified in the ICS database. The study cohort was 
186 cases with controlled HTN and 1732 with 
uncontrolled HTN in 2001 (Figure 1). All participants 
provided their informed consent to participate in the 
clinical examination and follow-up study. 
 
 
Figure 1: Flowchart of study participants 
HTN: Hypertension  
Cohort subjects in baseline 
(n = 6504) 
Study Cohort in 2001 
(n = 1918) 
 
Uncontrolled HTN 
(n = 1732) 
Controlled HTN 
(n = 186) 
Patient excluded due to 
having normal blood 
pressure 
(n = 4586) 
 
Subjects not attend 
in 2007’s survey 
(n = 917) 
Controlled 
subjects in 2007 
(n = 129) 
Uncontrolled 
subjects in 2007 
(n = 447) 
No Hypertension 
subjects in 2007 
(n = 239) 
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This sub-study sought to identify patient risk 
factors for uncontrolled blood pressure among 
Iranian patients with HTN. This study evaluated 
patients with a diagnosis of HTN over a 3-year 
period between 2001 and 2007. 
In addition, each subject had at least 3 HTN 
diagnostic coding events and at least 3-recorded 
BP readings. The minimum 3 blood pressure 
readings occurred within the 3-year study period 
and were obtained at separate office visits. A 
subject’s blood pressure was measured once, 
however, if elevated, a repeat BP was taken 5 min 
later. The lowest blood pressure reading was 
recorded. HTN was defined as systolic blood 
pressure (SBP) ≥ 140 mmHg and/or diastolic 
blood pressure (DBP) ≥ 90 mmHg17, HTN for 
diabetic and renal failure patients defined as 
defined, as a blood pressure ≥ 130/80 mmHg is an 
extremely common co-morbid condition in 
diabetes. Subjects who had an HTN diagnosis for 
< 6 months, patients with no medical record, and 
patients who were pregnant were excluded from 
the study. 
Uncontrolled HTN was defined as SBP and 
DBP more than 140/90 in the presence or absent 
of pharmacological treatment. 
After obtaining informed written consent, 
medical interview and physical examination were 
conducted. Measurements of blood pressure, 
anthropometric parameters, as well as fasting 
blood tests, were carried out following standard 
protocols and using calibrated instruments as has 
been described previously.18 Waist circumference 
(WC) was taken as the smallest circumference at or 
below the costal margin. HTN was defined as  
SBP ≥ 140 mm Hg or DBP ≥ 90 mm Hg in men 
and women or treatment of previously diagnosed 
HTN. Subjects who smoked daily were considered 
as current smoker. In 2007 (the 7th year of follow-
up), participants were invited for repeated 
laboratory measurements, physical examination 
and interview using the same protocol as a baseline 
survey. Laboratory measurement methods were 
similar in 2001 and 2007 but the auto analyzer was 
different (Eppendorf, Hamburg, Germany in 2001 
and Hitachi 902, Japan in 2007). Both instruments 
have been validated with an external standard 
laboratory center. 
Pharmacological treatment: using angiotensin-
converting enzyme inhibitor/angiotensin II 
receptor blocker, α-blocker, β-blocker, vasodilators, 
dihydropyridine calcium channel blocker, Non-
dihydropyridine calcium channel blocker, 
aldosterone antagonist, potassium-sparing diuretic, 
thiazide were consider in this study as mono-
therapy or combination therapy. 
Data are presented as number (percentage), 
means and standard deviation, chi-square and t-test 
were used to compare characteristics between two 
groups. Multiple logistic regression was used in an 
explanatory framework for evaluating the 
relationship between potential determinants of 
controlling HTN on all the derived demographic, 
administrative, and pharmacy records. The statistical 
software SPSS for windows (version 20.0, SPSS 
Inc., Chicago, IL, USA) was used. P < 0.050 was 
considered to be significant. 
Results 
A comparison of patient baseline characteristics for 
controlled and controlled HTN is presented in  
table 1. The prevalence of uncontrolled men was 
significantly higher than controlled in both 2001 
and 2007 (P < 0.001). No significant changes 
observed between educational level in both 2001 
and 2007 between subjects with and without 
controlled HTN (P = 0.265, P = 0.696). Regarding 
comorbid disease diabetes was significantly higher 
among uncontrolled subjects in 2001 and 2007  
(P < 0.001). Tendency to using salty food was 
significantly higher between controlled HTN and 
uncontrolled patients in 2001 (P < 0.001), but in 
2007 smoking habit was higher among uncontrolled 
subjects (P = 0.020). Mono-therapy by anti-
hypertensive drugs was more prevalent among 
subjects with controlled HTN (P = 0.001), similarly 
combination therapy by two antihypertensive drugs 
was more prevalent among patients with controlled 
HTN (P = 0.001).  
Table 2 shows demographic and clinical aspects 
of uncontrolled hypertensive subjects after 7 years 
of follow-up. After 6 years of follow-up, from 1732 
subjects who were uncontrolled HTN in 2001, 129, 
447 and 239 patients were controlled, uncontrolled 
and no signs of HTN respectively. Otherwise, 917 
subjects were lost of follow-up. Among above-
mentioned subjects mean of age was significantly 
higher among uncontrolled HTN (P < 0.001), 
whereas, no significant changes has seen regarding 
education and marital status (0.071, 0.291). Among 
co-morbid disease, obesity was more prevalent 
among controlled HTN subjects but diabetes and 
dyslipidemia was more prevalent among 
uncontrolled subjects. Lifestyle behavior except 
tendency to salty food has not any significant 
difference among groups. No drug usage is more 
prevalent among uncontrolled subjects (41.2%),  
(P < 0.001). 
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Table 1. Demographic characteristics of study participants based on control of hypertension (HTN) and year of follow-up 
 2001 2007 
Controlled Uncontrolled P Controlled Uncontrolled P 
Age 60.67 ± 11.14 57.39 ± 11.65 < 0.001 60.8 ± 10.63 60.8 ± 10.45 0.761 
Sex (male) 49 (26.34) 783 (45.20) < 0.001 82 (30.59) 488 (51.20) < 0.001 
Residency (rural) 36 (19.40) 515 (29.70) 0.003 57 (21.30) 277 (29.10) 0.011 
Education       
Illiterate 107 (57.52) 888 (51.27) 
0.265 
110 (41.04) 416 (43.65) 
0.696 Primary school 50 (26.88) 541 (31.23) 93 (34.70) 325 (34.10) More than primary school 29 (15.59) 303 (17.49) 65 (24.25) 212 (22.24) 
Insurance 235 (87.70) 827 (87.00) 0.754 - - 
Marital status       
Married 135 (72.58) 1491(86.08) 
< 0.001 
222 (83.14) 817 (86.00) 
0.125 Single 0 (0) 8 (0.50) 0 (0) 3 (0.30) Divorced 1 (0.50) 7 (0.40) 1 (0.40) 0 (0) 
Widowed 50 (29.60) 226 (13.00) 44 (16.50) 130 (13.70) 
Comorbid disease 
Obesity* 46 (24.73) 518 (29.90) 0.140 92 (34.32) 309 (32.42) 0.557 
Diabetes 8 (4.30) 375 (21.65) < 0.001 48 (17.90) 335 (35.20) < 0.001 
Dyslipidemia 22 (91.35) 1548 (91.00) 0.851 209 (78.00) 775 (81.30) 0.222 
Lifestyle Behavior 
Smoking habits 27 (14.50) 307 (17.80) 0.388 21 (7.90) 133 (14.40) 0.020 
Tendency to salty foods 116 (62.30) 1146 (66.20) < 0.001 87 (32.60) 303 (31.00) 0.113 
Physical inactivity 149 (80.10) 1416(81.75) 0.581 213 (79.47) 743 (77.96) 0.595 
Pharmacological treatment  
Mono-therapy 132 (70.90) 458 (26.40) 
< 0.001 
172 (64.20) 311 (32.60) 
0.006 
Combination therapy by Two drug 10 (5.40) 66 (3.80) 37 (13.80) 70 (7.30) 
Combination therapy by three 4 (2.10) 9 (0.51) 15 (5.60) 14 (1.50) 
No drug usage 40 (21.50) 1199 (69.20) 44 (16.40) 558 (58.50) 
Knowledge 186 (100.00) 1623 (93.70) 268 (100) 919 (97.20) 
Practice 127 (68.27) 453 (61.88) 0.106 101 (37.70) 166 (31.80) 0.098 
*
 Obesity defined as (body mass index > 30) 
 
Table 2. Demographic and clinical aspects of uncontrolled hypertensive subjects after 7 years of follow-up 
Subjects in 2007 Subjects with Uncontrolled Hypertension in 2001 (n = 1732
*) 
Controlled (n = 129) Uncontrolled (n = 447) No hypertension (n= 239) P  
Age 62.66 ± 10.62 67.81 ± 10.04 58.86 ± 11.57 < 0.001 
Sex (male) 38 (29.50) 209 (46.80) 119 (49.80) < 0.001 
Education    
0.071 Illiterate 56 (43.40) 213 (47.70) 88 (36.80) Primary school 44 (34.10) 146 (32.70) 86 (36.00) 
More than primary school 29 (22.50) 88 (19.70) 65 (27.20) 
Marital Status    
0.291 
Married 111 (86.7) 377 (84.7) 209 (88.2) 
Single 0 (0.0) 0 (0.0) 1 (0.4) 
Divorced 1 (0.8) 0 (0.0) 0 (0.0) 
Widowed 16 (12.5) 68 (15.3) 27 (11.4) 
Co morbid disease     
Obesity 52 (40.3) 151 (33.8) 65 (27.2) 0.032 
Diabetes 32 (24.8) 190 (42.5) 52 (21.8) < 0.001 
Dyslipidemia 103 (79.8) 365 (81.7) 174 (72.8) 0.025 
Lifestyle Behavior     
Smoking Habits 6 (4.7) 23 (5.2) 21 (8.9) 0.127 
Tendency to salty Foods 64 (50.0) 243 (54.5) 159 (67.4) 0.001 
Physical inactivity 100 (77.5) 345 (77.2) 188 (78.7) 0.905 
Drugs    
< 0.001 
One drug 76 (58.9) 202 (45.2) 0 (0.0) 
Two drugs 24 (18.6) 50 (11.2) 0 (0.0) 
Three drugs 9 (7.0) 11 (2.5) 1 (0.4) 
No drugs 15(15.5) 184(1.2) 238 (9.6) 
*
 917 subjects did not attend the 2007 survey. 
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Table 3. Assessment factors affecting on the uncontrolled hypertension (HTN) 
 
2001 2007 
OR (95% CI) P OR (95% CI) P 
Age 0.97 (0.96-0.98) < 0.001 1.00 (0.99-1.01) 0.987 
Sex (male) 2.31 (1.64-3.24) < 0.001 2.38 (1.78-3.18) < 0.001 
Education     
Illiterate 1  1  
Primary school 1.30 (0.92-1.85) 0.140 0.92 (0.68-1.26) 0.620 
More than primary school 1.26 (0.82-1.94) 0.294 0.86 (0.61-1.22) 0.405 
Marital status     
Married 1  1  
Single - - - - 
Divorced 0.63 (0.77-5.19) 0.671 - - 
Widowed 0.41 (0.29-0.58) < 0.001 0.80 (0.55-1.16) 0.248 
Comorbid disease*     
Obesity 1.29 (0.92-1.84) 0.142 0.92 (0.69-1.22) 0.558 
Diabetes 6.15 (3.00-12.60) < 0.001 2.48 (1.77-3.48) < 0.001 
Dyslipidemia 0.95 (0.55-1.63) 0.857 1.22 (0.88-1.71) 0.223 
CVD 1.25 (0.81-1.93) 0.313 0.68 (0.48-0.97) 0.031 
Lifestyle behavior     
Smoking habits 1.27 (0.83-1.95) 0.270 1.88 (1.03-3.42) 0.040 
Tendency to salty foods 1.73 (1.20-2.50) 0.003 1.29 (0.98-1.69) 0.069 
Physical inactivity 0.89 (0.61-1.31) 0.582 1.09 (0.74-1.52) 0.596 
Pharmacological treatment     
No drugs 1 - 1 - 
Mono-therapy 0.12 (0.09-0.18) < 0.001 0.14 (0.10-0.20) < 0.001 
Combination therapy by two drug 0.27 (0.11-0.65) 0.002 0.15 (0.90-0.20) 0.085 
Combination therapy by three drug 0.08 (0.02-0.27) < 0.001 0.7 (0.30-0.20) 0.095 
Control hypertension (HTN) consider as reference group; Control of Co-morbid disease consider as not having these conditions; OR: 
Odds ratio; CI: Confidence interval; CVD: Cardiovascular disease 
 
Odds ratios (ORs) > 1 were associated with 
uncontrolled HTN, and ORs < 1 were associated 
with controlled HTN (Table 3). A significant 
association was found between sex and control of 
blood pressure; compared with women, being men 
(OR = 2.31; 95% CI = 1.64-3.24) was significantly 
associated with uncontrolled HTN in 2001 and  
(OR = 2.38; 95% CI = 1.78-3.18). Education was 
not associated with blood pressure control in both 
2001 and 2007 [OR = 1.26; 95% CI = 1.26  
(0.82-1.94) and OR = 0.86, 95% CI (0.61-1.22) 
respectively]. However, partner status has associated 
with uncontrolled blood pressure (OR, 0.41; 95% 
CI [0.29-0.58]) Diabetes considered as a powerful 
predictor for controlled HTN in both 2001 and 
2007 [2001: OR = 6.15; 95% CI (3.00-12.60), 2007: 
OR = 2.48; 95% CI (1.77-3.48), respectively]. 
Among lifestyle behaviors, tendency for more 
consumption of salty foods increased the risk of 
uncontrolled HTN in 2001 by 1.73 times  
[OR = 1.73, 95% CI (1.20-2.50), (P = 0.003)] but 
this item was not associated with control of blood 
pressure in 2007 (P = 0.069). Patients who were 
naive to mono-therapy without considering the type 
of antihypertensive drug were found to be 
associated with uncontrolled blood pressure  
[OR = 0.14; 95% CI (0.1-0.2)]. 
Discussion 
This retrospective cohort study recognized major 
patient features associated with uncontrolled HTN 
were sex, marital status, diabetes, tendency to salty 
foods and medication adherence. To the best of our 
knowledge, this is the first report, which focused on 
uncontrolled HTN in a sample of cohort Iranian 
population. Similarly, Egan et al. demonstrated this 
sex-dependent uncontrolled HTN.12 Marital status also 
showed a significant relationship with HTN control, 
partnered hypertensive patients were at higher risk of 
uncontrolled HTN. Studies conducted in Europe also 
evaluated partner status, and its association with HTN. 
Similarly, in a Dutch population, patients without a 
partner were found to have had a higher risk for 
uncontrolled HTN.19 Similarly, de Gaudemaris et al.20 
and Lessa et al.21 studied on French population 
observed that single men might have had an 
association with the prevalence of HTN; however, this 
finding was not statistically significant. 
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Our results showed education could not play a 
crucial role to having controlled HTN. Similar to 
our obtained results, a recent study in Brazil has 
shown that education was not a good predictor for 
adherence to treatment of HTN.22 Association of 
cardiovascular risk factors and blood pressure was 
described previously.23-25 But how other 
cardiovascular risk factors could effect on the 
control of HTN is still on in debt. Our data showed 
that there is a potentially negative role of diabetes in 
the control of HTN for hypertensive patients. 
Similarly, Bog-Hansen et al. showed uncontrolled 
blood pressure is in both sexes related to type 2 
diabetes.26 The VIIDA registry, which was also 
carried out in Spain, identified DM and left 
ventricular hypertrophy as the main factors 
associated with lack of BP control.27 
In this study, although central obesity in subjects 
with uncontrolled HTN was significantly higher than 
other group but overall obesity was not significantly 
associated with control of blood pressure. Previously, 
Cordero et al. discussed the effect of metabolic 
alterations associated with obesity might be 
associated with the intra-abdominal visceral fatty 
mass.28 In effect, it was shown that the type of 
visceral adipose tissue was associated with intolerance 
to glucose and high lipid levels, even after adjustment 
for BMI and age. The link between smoking and 
CVD has been evidently recognized. Our results 
show that smoking is also associated with 
uncontrolled HTN. Smoking induces endothelial 
dysfunction, vasoconstriction, insulin resistance, and 
dyslipidemia, certain forms of which could explain 
our results.29 Instead, smokers are more sedentary 
and have unhealthy diets, and these are factors, 
which can directly raise blood pressure. Subjects with 
unhealthful lifestyles such as propensity to salty foods 
and diets are also associated with poorer with blood 
pressure control.30 
We also found that age and CVD were 
associated with blood pressure control, which could 
reflect CVD subjects have better practice about 
their disease. It seems that these patients are more 
aware of control of HTN. The number of 
antihypertensive drugs used showed a much weaker 
association with control of blood pressure. We did 
not find any significant difference between type of 
one drug and control of HTN (data not showed) 
but these results showed without considering the 
type of antihypertensive drugs, treatment by one or 
two drug could not useful to control of HTN, so 
combination therapy may be useful based on clinical 
aspects of penitents. Treatment guidelines note that 
the combination of an angiotensin receptor blocker 
and a calcium channel blocker, similar to the 
combination of an angiotensin-converting enzyme 
inhibitor or an ARB plus a diuretic, provides an 
effective option for patients with HTN. 
For greater success, treatment must always be 
associated with other non-pharmacological 
interventions. The cost of medication may be a barrier 
for the control of HTN and must be an important 
factor in the choice of antihypertensive drugs. 
The results of the study that done by Allemann 
et al. showed combining antihypertensive drugs 
with complementary mechanisms of action for the 
treatment of patients with HTN. They indicated 
that combination therapy lowers blood pressure to a 
greater degree than mono-therapy.31 
Study strengths and limitations 
These studies strengthen to random and large patient 
population reflecting the communities from which it 
was drawn. In addition, a large number of variables 
were investigated to explore multiple associations 
with uncontrolled blood pressure. Although some 
previous studies reported acceptable control of 
HTN, but their results were limited to small sample 
size which were under control by regular clinic 
visiting. However, several limitations exist in our 
investigation. First, there are inherent limitations 
associated with the retrospective cohort study design. 
Second, in our questionarie we asked about attitude 
and practice of patients regarding control of HTN 
but there is a lack of data regarding regular visiting 
patients in clinics or home monitoring. 
Conclusion 
Uncontrolled HTN was sex, marital status, diabetes, 
tendency to salty foods and medication adherence. 
Assessment of them presence of these risk factors is 
warranted to recommend an aggressive HTN 
management with the goal of reducing excessive risk 
of cardiovascular events caused by uncontrolled HTN. 
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